bioRASI
 
bioRASI serves North America, Europe and Asia
Recent News
April 2012
bioRASI announces sponsorship of Evolution Summit in Chicago
bioRASI wins award for CRO outstanding quality
bioRASI submits comments to FDA regarding draft guidelines on the regulation of biosimilars.
March 2012
bioRASI announces the formation of a Biotherapeutics Division to accommodate growing business in this area.
Feb 2012
bioRASI completes phase II trial for an antimicrobial in wound healing.
read more

Everyday, in clinical settings around the world, leading biotech and pharmaceutical companies count on bioRASI to help optimize their clinical development programs.


bioRASI’s clients benefit from its access to patients and special populations in the U.S., Europe and Asia, to achieve unparalleled scientific, clinical and business results significantly faster and at lower costs.


bioRASI accelerates the process of obtaining FDA approvals with a full spectrum of services, including:


Program Optimization
Project Management
Regulatory
Clinical
Data Management & Analysis
Compliance & Audit


bioRASI is headquartered in Miami, FL and has regional offices, labs, and clinics across the U.S. and overseas.
Clinical Research Optimized
Everyday, in clinical settings around the world, leading biotech and pharmaceutical companies count on bioRASI to help optimize their clinical development programs.


bioRASI’s clients benefit from its access to patients and special populations in the U.S., Europe and Asia, to achieve unparalleled scientific, clinical and business results significantly faster and at lower costs.


bioRASI accelerates the process of obtaining FDA approvals with a full spectrum of services, including:


Program Optimization
Project Management
Regulatory
Clinical
Data Management & Analysis
Compliance & Audit


bioRASI is headquartered in Miami, FL and has regional offices, labs, and clinics across the U.S. and overseas.
bioRASI Process InfrastructureTM (BPI)

bioRASI Process Infrastructure (BPI-2012) is a comprehensive, well-structured set of documents that guides our project teams from the initial interactions with the Sponsor through regulatory agency submission. It integrates industry-leading project management practices with ICH-GCP compliant procedures to create a seamless process infrastructure that ensures optimal performance and the highest quality outcomes.

Like all top-tier performance management systems, BPI is continuously upgraded. We believe BPI contributes to bioRASI’s superiority in conducting clinical trials.

Combination Products
Point of Care and Patient Use Devices
IDE and 510k
Innovative Biotherapeutics
Cell-Based Therapies
Biosimilars
Biotherapeutics Division
flower and pills
bioRASI releases a series of white papers on clinical endpoint ANDA and 505(b)(2) Program Optimization Techniques.


To receive a copy...

eye dropper
 

F u l l   S e r v i c e   G l o b a l   C R O